| Tag | Content |
|---|
EnhancerAtlas ID | HS109-05877 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr12:104962350-104964500 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Gata1 | MA0035.3 | chr12:104962484-104962495 | ACAGATAAGGA | - | 6.14 | | IRF1 | MA0050.2 | chr12:104962946-104962967 | TAAATAAAAGTGAAACTACTA | - | 7.12 | | RORA(var.2) | MA0072.1 | chr12:104962672-104962686 | TAAAAGTAGGTCAT | + | 6.35 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_09142 | chr12:104958996-104964925 | CD14 | | SE_49965 | chr12:104960749-104964575 | RPMI-8402 | | SE_66484 | chr12:104960756-104964581 | Jurkat |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr12 | 104962400 | 104963200 | | chr12 | 104963668 | 104963866 |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH12I104567 | chr12 | 104961607 | 104962378 | | GH12I104568 | chr12 | 104962438 | 104965578 |
|
Enhancer Sequence | TGATCATGGG AGCTGCTGAT GGGACCTCCC CTAGAGATAC AATGACAGCG GCACCTGTCA 60
TCTCTACTAT TATCTATAAT GTGGCTTGTA TTTATCAACT CACTTAAACC TGCAGGCAGT 120
ATTATCTCCA TTTTACAGAT AAGGAAACTA AAGCTCAGAG AGGTTAAGTA ACTTGACCAA 180
ATTAACACAG TGAAAAAGGG GCAGAGCTGG GATCCAATCC CAGGCAATAT GGCTTTATAG 240
TTCATGTTCT TAACCACTAT TTTATACTGC CTCTGTATTT CTAAACTAAA AGTTGAAACC 300
TACCATTGGA GATCTTTAAA AATAAAAGTA GGTCATTAGC TCTTTAAGAC AGTCTATGTA 360
TGTAGCGACA TTTATTAAAT ACTGACTGAA TAAAGTACCT AAGAGTATGC CAGGTACTCT 420
TCTAGTTGCT CTCATGTATT AGCTCATTAA TCCCCACAAC ACTCCTGAGA GGTAAGTATT 480
ATTATTTTCA TCCCCATTTT GCAGAGGAGA AAACTGAGGC ATGGAGAGGG TTAGTATCCA 540
CGGTCACAGA GCCAGGATGT GACAGGACTG GAACCCAATT GTCTGGCTCT AGATTCTAAA 600
TAAAAGTGAA ACTACTAGCT TATGAAACAA AATTTGACAA ACCTCTCAAC TTGGTTATTC 660
TGACGGAAGA AATTCTAGGA ATAGAGAACC CTCCTGGAGT TACCGTCTTA GTTACTAGAG 720
CTCAGTTTGT GAGACTCCAT AGCTTTTCAG AATATTTTAT ATTCTGAATA AAAAAATGCA 780
CACAACAAAA ACAACCAGAT ACATTTGTTC AAAGGAACGA TCCTCAGGAT TTGTGGACAG 840
TTCACTTCGA GACCAGTGTC TCTTACAATC TCAGTTTTCT GTCCTGAGCA GTTACCTTCA 900
AAACTTAGGG GAAGAGCTCA GAGGATGTCT GAGTCCATTT TGCATCTTCA TCACACAGAG 960
CTCTGTGGCT GAGTGCATCA TAGCTCTTAG GTACAGCAGA CCTATTGGAT TGATCAGCAG 1020
CAGAACTGTT ATGCCTGGGG TAAGAACATA ATGAAGTGGG GGAGATTCCA AGCTAGGAAT 1080
TTGGGGCCCA GATTCTAGGG GATGCCTCCA GGGTTTTCAG GCTGCACCTT CTCCATTGAT 1140
CTGCCCAGTT TATGGAGCCA CAGGGGAATA AGTCCTGCTA TTGAAGGTGA TGTTGGTGCA 1200
GGTGGTATTG GGGTGGCACC ATTGACCATG CTGCACTGGG AGTCCCCAAC CCTGGGCTTT 1260
CCCTTTTGAG GTTCAGTGTA GGCTCTTGAT TCTGCTTCAT AATCTTACTT TACAGTTGGA 1320
GGAAGAGGAC GGGTTGCGAA AGGAACTTCC TTTGCATGCG GTCAGAGTGC TGGGCCATCT 1380
GAACAGCCCC CTCCACGGTC TGCAACATTT CTACATTCTG ATAGAAACAG TTAGTGGTCT 1440
TGACGTGTCT GACAACCTAC AAAACCAACA TATCCTGGGG TTTGATCTCT CTGGTGGTGT 1500
CAGAGGAGTC CAAAGTGAGC ATCTGTAAGC TCGGCTGTGA TCCAGCCTAT TTGGGAGGAT 1560
CTGTATTAAA CCAGTGACTG CCCTCCCCAC CCCACCTCTA CTCCTAAAGG GTTCTGTTTC 1620
ACAAGAGCCA GGCTCAGGTA CCTGTTTTTC TCCACCCACA CCTTGTTTAT TCCTCTTTTC 1680
CTCACTGTCT TCGTTGTTGT TCTTGTTGTA TATGAGAAAA TCGACTCATT TTTAACATTT 1740
CGCAAGCCTC CCCCTCCCAC TAGTAGGTGT GTGAGCAGCT GCAGATTTTA CCGTCTGTAA 1800
ACCTTCCACA CTCCAGCAGA TCCTCTTTCC ACCTTTCAGC ACTGTGCAGC CCACCCAAGC 1860
CACGTGCCTT CTTGGTGTCC CATCTATGCC TCTCTCTGAA ATCAGGAACC AAGCTCACTG 1920
GGGATGAGCA TGGCAGGACC TCAGGAAGAA GCCTACTCCT TTCCTTCCTG CAAGAAAATG 1980
TGCCAGGCAT TTAGTATTAG GGATACAGAA GTGGATACAC AAGATTCTTG CCTTCAAGCA 2040
ACTCGGGAAT TTAGAAGGAA TAGCAACAGT ATTAACAATT GCTACCATTT ATTCAGTTTC 2100
AGTATATGTA AGCCACTGCA CTTTTTTTTT TTTTTTGAGA CTGAGTCTCG 2150
|
